Radiation Oncology Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Radiation 
Oncology Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r ep o r t  by  I M AR C G r ou p ,  t i t l ed  "R ad i a t i on  O n co l og y  M arke t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  r ad ia t i on  onc o logy  m ar k e t  s i ze  r e ach ed  US $  8 . 1  B i l l i on  i n  20 23 .
Factors  Af fect ing the  Growth of  the Radia t ion Oncology Indust ry :
Report Technologica l  Innovat ions:
O ng o ing  Adv ance m en t s  i n  r ad ia t i on  t h e r ap y  t ec hno log ies  suc h  a s  i n t ens i t y -
m od u la t ed  r ad i a t i on  t he r a py  ( I M RT ) ,  s t e r eo t a c t i c  bo dy  r ad ia t i on  t he r ap y  ( SBR T) ,  
Highlight and and  p r o t on  t h e r ap y  h ave  s ign i f i can t l y  im p r o ved  t r e a t m en t  p r ec i s ion ,  e f f i cac y ,  and  
pa t i en t  ou t com es .  Th ese  i n nova t i ons  e nab le  m or e  t a r g e t ed  d e l i ve r y  o f  r ad ia t i on  t o  
t um or  s i t es  wh i l e  s pa r ing  he a l t hy  su r r ound ing  t i s su e ,  r edu c ing  s ide  e f f e c t s  and  
Description im p r ov ing  t he  qua l i t y  o f  l i f e  f o r  pa t i en t s .  
Add i t i ona l l y ,  t h e  i n t eg r a t i on  o f  im ag ing  m oda l i t i es  such  as  M RI  an d  PE T- CT  i n t o  
t r ea t m en t  p lann ing  a l l o ws  f o r  be t t e r  v i s ua l i za t i on  o f  t um or s ,  f ac i l i t a t i ng  pe r s ona l i z ed  
t r ea t m en t  app r oache s .  The  con t in uous  de ve lop m en t  o f  nov e l  r ad ia t i on  de l i v e r y  
t ech n ique s  and  im ag ing  t ech no log ies  d r i ve s  m ar k e t  g r o w t h  by  expan d ing  t r e a t m en t  
op t i ons  a nd  im pr ov i ng  c l i n i ca l  o u t com es .
Ris ing Cancer  Incidence and Prevalence:
The  i nc reas ing  g loba l  burden o f  cance r ,  f ue led  by  fac to rs  such  as  ag ing  
popu la t i ons ,  l i f es t y le  changes ,  and  env i ronm en ta l  f ac t o r s  has  augment ed  the  
demand  fo r  r ad ia t ion  onco logy  se rv ices .  Apar t  f rom th i s ,  rad ia t ion  the rapy  p lays  a  
c ruc ia l  ro le  in  t he  t r ea t men t  o f  var ious  cancers ,  i nc lud ing  pros ta t e ,  b reas t ,  l ung ,  
Report and  b ra in  cancers ,  e i t her  as  a  p r im ary  t r ea tmen t  moda l i t y  o r  in  comb ina t i on  w i t h  
su rge ry  and  chemothe rapy .  
Highlight and As cancer  inc idence  and  preva lence con t i nue  t o  r i se  wor ldwide ,  par t i cu la r l y  i n  deve lop ing  reg ions ,  t he re  has  been  a  r i se  in  demand  fo r  r ad ia t ion  onco logy  
se rv ices ,  bo ls t e r i ng  marke t  expans ion .
Description Strateg ic  Partnerships and Col laborat ions:
Col l abora t ion  be tween  hea l thca re  p rov iders ,  t echno logy  deve lope rs ,  and  research  
ins t i t u t i ons  i s  d r i v ing  innova t ion  and marke t  g rowth  in  rad ia t ion  onco logy .  
Par tnersh ips  be t ween  rad ia t ion  the rapy  cen ter s  and  academic  med ica l  cen t ers  
fac i l i t a t e  c l i n i ca l  t r i a l s ,  research ,  and  deve lopmen t  o f  new t rea tment  p ro toco ls .  
Add i t i ona l l y ,  co l l abora t ions  be tween  rad ia t ion  t he rapy  equ ipmen t  manuf ac tu rer s  
and  so f t ware  deve lope rs  lead  to  the  in t egra t ion  o f  advanced f ea tu res  and 
func t iona l i t i es  in t o  t rea tment  p lann ing  and  de l i ver y  sys t ems .
Fur thermore ,  s t ra teg ic  a l l iances  be tween  hea l thcare  ins t i t u t ions  and  insurance  
p rov ide rs  p romote  re imbursement  fo r  rad ia t ion  the rapy  se rv i ces ,  expand ing  
access  to  ca re  and  d r iv ing  marke t  g rowth .  These  par tne rsh ips  and  
co l labora t ions  fos te r  a  synerg is t i c  env i ronment  fo r  innova t ion ,  research ,  and  
marke t  expans ion  in  rad ia t ion  onco logy .
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/ rad ia t ion -onco logy-marke t / reques tsamp le
Description
Report Description
Global Radiation Oncology Market Trends:
The g lobal  rad ia t ion oncology market  is  pr imar i ly  dr iven by ongoing advancements in  rad ia t ion 
therapy technolog ies,  such as In tens i ty Modulated Radiotherapy ( IMRT) and Image-Guided Radiat ion 
Therapy ( IGRT),  which enable more prec ise target ing of  tumors whi le  min imiz ing damage to  
sur rounding heal thy t issue,  improving t reatment  outcomes,  and reducing  s ide ef fects .  
Addi t iona l ly ,  the r is ing preva lence of  cancer  wor ldwide,  a t t r ibuted to  factors l i ke  ag ing populat ions 
and l i fes ty le  changes has augmented the demand for  rad ia t ion oncology serv ices.  Fur thermore ,  
increas ing investments  in  heal thcare in f rastructure,  par t icu lar ly  in  emerg ing economies,  expand 
access to  advanced rad ia t ion therapy t reatments,  thus s t imulat ing market  growth .
View Report  TOC, F igures and Tables :  ht tps: / /www.imarcgroup.com/radiat ion-oncology-market
Breakup by Type:
• External  Beam Radiat ion Therapy
o Linear Accelerators
o Compact  Advanced Radiotherapy Systems
o Proton Therapy
• Internal  Beam Radiat ion Therapy
Report o Brachytherapy
o Systemic Beam Radiat ion Therapy
Segmentation o Others
Breakup by Technology:
• Image-Guided Radiotherapy ( IGRT)
• Intensity Modulated Radiotherapy ( IMRT)
• Stereotact ic  Technology
• Proton Beam Therapy
• 3D Conformal Radiotherapy (3D CRT)
• Volumetric Modulated Arc Therapy (VMAT)
• Brachytherapy
Breakup by Application:
Report 
• Prostate Cancer
Segmentation • Breast Cancer
• Lung Cancer
• Head and Neck Cancer
• Colorectal  Cancer
• Gynecological  Cancer
• Cervical  Cancer
• Peni le Cancer
• Others
Breakup by End User:
• Hospitals
• Cancer Research Insti tutes
Report 
• Ambulatory and Radiotherapy Centers
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Accuray Incorporated
• Becton Dickinson and Company
• Canon Inc.
• Elekta
Competitive • Hitachi  Ltd.
Landscape • Icad Inc.
• Ion Beam Appl icat ions
with Key • Isoray Inc.
Players • Mevion Medical  Systems Inc.
• Nordion (Canada)  Inc.  (Sotera Health)
• P-Cure Ltd.
• Varian Medical  Systems Inc.  (S iemens 
Healthineers  AG)
• ViewRay
How has the global radiation oncology market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global radiation oncology market?
What is the impact of each driver, restraint, and 
Key opportunity on the global radiation oncology market?
Questions What are the key regional markets?
Answered in 
Which countries represent the most attractive radiation 
oncology market?
the Report
What is the breakup of the market based on the type?
Which is the most attractive type in the radiation 
oncology market?
What is the breakup of the market based on 
technology?
Which is the most attractive technology in the radiation 
oncology market?
What is the breakup of the market based on the 
application?
Which is the most attractive application in the radiation 
Key oncology market?
Questions What is the breakup of the market based on the end-
user?
Answered in 
Which is the most attractive end-user in the radiation 
the Report oncology market?
What is the competitive structure of the market?
Who are the key players/companies in the global 
radiation oncology market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s
5     G l o b a l  R a d i a t i o n  O n c o l o g y  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     E x t e r n a l  B e a m  R a d i a t i o n  T h e r a p y
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  L i n e a r  A c c e l e r a t o r s
           6 . 1 . 2 . 2  C o m p a c t  A d v a n c e d  R a d i o t h e r a p y  S y s t e m s
           6 . 1 . 2 . 3  P r o t o n  T h e r a p y  
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     I n t e r n a l  B e a m  R a d i a t i o n  T h e r a p y
       
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  B r a c h y t h e r a p y  
           6 . 2 . 2 . 2  S y s t e m i c  B e a m  R a d i a t i o n  T h e r a p y
           6 . 2 . 2 . 3  O t h e r s  
        6 . 2 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     I m a g e - G u i d e d  R a d i o t h e r a p y  ( I G R T )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
Table of     7 . 2     I n t e n s i t y  M o d u l a t e d  R a d i o t h e r a p y  ( I M R T )        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     S t e r e o t a c t i c  T e c h n o l o g y
Contents         7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     P r o t o n  B e a m  T h e r a p y
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     3 D  C o n f o r m a l  R a d i o t h e r a p y  ( 3 D  C R T )
        7 . 5 . 1  M a r k e t  T r e n d s
        7 . 5 . 2  M a r k e t  F o r e c a s t
    7 . 6     V o l u m e t r i c  M o d u l a t e d  A r c  T h e r a p y  ( V M A T )
        7 . 6 . 1  M a r k e t  T r e n d s
        7 . 6 . 2  M a r k e t  F o r e c a s t
    7 . 7     B r a c h y t h e r a p y
        7 . 7 . 1  M a r k e t  T r e n d s
        7 . 7 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m / ra d ia t i o n - o nc o lo gy-m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: